- Conditions
- Respiratory Tract Infection, Respiratory Syncytial Virus
- Interventions
- Clesrovimab, Placebo
- Drug
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Eligibility
- 2 Weeks to 8 Months
- Enrollment
- 183 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2022
- U.S. locations
- 17
- States / cities
- Aurora, Colorado • Homestead, Florida • Miami, Florida + 14 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 42
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Minimally invasive surfactant therapy, Continuation on CPAP
- Device · Other
- Lead sponsor
- Menzies Institute for Medical Research
- Other
- Eligibility
- 1 Minute to 6 Hours
- Enrollment
- 486 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2022
- U.S. locations
- 5
- States / cities
- New Haven, Connecticut • Honolulu, Hawaii • Evanston, Illinois + 2 more
- Conditions
- Respiratory Distress Syndrome, Pre-term Infants
- Interventions
- APC-0101 (SF-RI 1 surfactant for inhalation combined with a dedicated delivery system), Control
- Combination Product · Other
- Lead sponsor
- Aerogen Pharma Limited
- Industry
- Eligibility
- 1 Hour to 24 Hours
- Enrollment
- 520 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 12
- States / cities
- Little Rock, Arkansas • La Jolla, California • Jacksonville, Florida + 9 more
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- CHF5633, Poractant alfa
- Drug
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Industry
- Eligibility
- 1 Hour to 24 Hours
- Enrollment
- 123 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 23
- States / cities
- Mobile, Alabama • Los Angeles, California • Orange, California + 20 more
- Conditions
- Respiratory Syncytial Virus Infections
- Interventions
- MEDI8897, Placebo
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 0 Years to 1 Year
- Enrollment
- 3,012 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2023
- U.S. locations
- 66
- States / cities
- Birmingham, Alabama • Fort Defiance, Arizona • Fayetteville, Arkansas + 59 more
- Conditions
- Premature Birth of Newborn
- Interventions
- Kangaroo Care
- Other
- Lead sponsor
- Case Western Reserve University
- Other
- Eligibility
- 7 Days to 37 Weeks
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2015
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Bronchopulmonary Dysplasia, Prematurity
- Interventions
- Protocolized weaning of respiratory support
- Other
- Lead sponsor
- Christiana Care Health Services
- Other
- Eligibility
- 22 Weeks to 30 Weeks
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Newark, Delaware
- Conditions
- Infant, Premature
- Interventions
- Not listed
- Lead sponsor
- University of Virginia
- Other
- Eligibility
- Up to 1 Week
- Enrollment
- 739 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 1
- States / cities
- Charlottesville, Virginia
- Conditions
- Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Retinopathy of Prematurity, Bronchopulmonary Dysplasia (BPD)
- Interventions
- Inositol lower volume, Inositol mid-level volume, Inositol high volume, Placebo low volume
- Drug
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- 12 Hours to 72 Hours
- Enrollment
- 125 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2013
- U.S. locations
- 17
- States / cities
- Birmingham, Alabama • Palo Alto, California • New Haven, Connecticut + 13 more
- Conditions
- BPD - Bronchopulmonary Dysplasia, Apnea of Prematurity, Hemodynamic Instability, Intubation
- Interventions
- Caffeine Citrate, Placebo (Normal Saline)
- Drug
- Lead sponsor
- Jennifer Shepherd
- Other
- Eligibility
- Up to 1 Day
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 2
- States / cities
- Los Angeles, California
- Conditions
- Respiratory Syncytial Virus Infection
- Interventions
- Clesrovimab, Placebo
- Biological · Drug
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Eligibility
- Up to 1 Year
- Enrollment
- 3,632 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2024
- U.S. locations
- 51
- States / cities
- Dothan, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 45 more
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- Betamethasone
- Drug
- Lead sponsor
- Emory University
- Other
- Eligibility
- Female only
- Enrollment
- 67 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2007
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Respiratory Syncytial Virus
- Interventions
- Placebo, MEDI8897 10 mg, MEDI8897 25 mg, MEDI8897 50 mg
- Drug
- Lead sponsor
- MedImmune LLC
- Industry
- Eligibility
- Up to 12 Months
- Enrollment
- 151 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2016
- U.S. locations
- 7
- States / cities
- Anaheim, California • Ontario, California • Syracuse, New York + 4 more
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Gastric Feeds, Jejunal Feeds
- Procedure
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 0 Hours to 1 Year
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Respiratory Syncytial Virus Infections
- Interventions
- Suptavumab 30 mg/kg, Placebo Matched to Suptavumab, Suptavumab 30 mg/kg- 1 Dose, Suptavumab 30 mg/kg - 2 Doses
- Drug
- Lead sponsor
- Regeneron Pharmaceuticals
- Industry
- Eligibility
- Up to 6 Months
- Enrollment
- 1,177 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2017
- U.S. locations
- 107
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Little Rock, Arkansas + 104 more
- Conditions
- Infant,Premature
- Interventions
- Cardiorespiratory monitoring
- Diagnostic Test
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 1 Day to 98 Days
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Transient Tachypnea
- Interventions
- Prophylactic CPAP Administration
- Other
- Lead sponsor
- New York Hospital Queens
- Other
- Eligibility
- 2 Minutes to 30 Minutes
- Enrollment
- 138 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2013
- U.S. locations
- 1
- States / cities
- Flushing, New York
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- Endotracheal tube insertion, Laryngeal mask airway insertion
- Device
- Lead sponsor
- Albany Medical College
- Other
- Eligibility
- 4 Hours to 48 Hours
- Enrollment
- 61 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2012
- U.S. locations
- 1
- States / cities
- Albany, New York
- Conditions
- BPD - Bronchopulmonary Dysplasia
- Interventions
- NAVA technology to synchronize NIPPV
- Device
- Lead sponsor
- New York Medical College
- Other
- Eligibility
- 24 Weeks to 30 Weeks
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2022
- U.S. locations
- 1
- States / cities
- Valhalla, New York
- Conditions
- Apnea of Prematurity
- Interventions
- Caffeine Citrate, Placebo
- Drug
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- 29 Weeks to 33 Weeks
- Enrollment
- 827 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2023
- U.S. locations
- 16
- States / cities
- Birmingham, Alabama • Palo Alto, California • Atlanta, Georgia + 12 more
- Conditions
- Infant,Premature
- Interventions
- Cardiorespiratory monitoring
- Diagnostic Test
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 1 Day to 15 Days
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Patent Ductus Arteriosus, Preterm Infant, Bronchopulmonary Dysplasia
- Interventions
- Ibuprofen and acetaminophen, Ibuprofen and placebo
- Drug
- Lead sponsor
- University of South Alabama
- Other
- Eligibility
- 5 Days to 21 Days
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Mobile, Alabama
- Conditions
- Ventilator-Induced Lung Injury, Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Preterm Infant
- Interventions
- Mid frequency ventilation, Standard frequency ventilation
- Device
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 1 Day to 3 Days
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2024
- U.S. locations
- 2
- States / cities
- Birmingham, Alabama • Mobile, Alabama
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- Fluid Management Intervention
- Other
- Lead sponsor
- University of Oklahoma
- Other
- Eligibility
- Up to 12 Hours
- Enrollment
- 65 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2021
- U.S. locations
- 2
- States / cities
- New York, New York • Lawton, Oklahoma